Evaluation of patupilone as monotherapy in patients with advanced hepatocellular carcinoma (HCC)

被引：0
|
作者：
Venook, A. P.
Poon, R.
Kang, Y. K.
Mok, T. S.
Chao, Y.
de Bedout, S.
Harbott, A.
Li, J.
Johri, A. R.
机构：
[1] Univ Calif San Francisco, San Francisco, CA 94143 USA
[2] Univ Hong Kong, Queen Mary Hosp, Hong Kong, Peoples R China
[3] Asan Med Ctr, Seoul, South Korea
[4] Chinese Univ Hong Kong, Hong Kong, Peoples R China
[5] Vet Gen Hosp, Taipei, Taiwan
[6] Novartis Pharmaceut, E Hanover, NJ USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2007年 / 25卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
15055
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Regorafenib in advanced hepatocellular carcinoma (HCC): considerations for treatment
    Kim, Kyung
    Jha, Reena
    Prins, Petra A.
    Wang, Hongkun
    Chacha, Monica
    Hartley, Marion L.
    He, Aiwu Ruth
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2017, 80 (05) : 945 - 954
  • [22] Regorafenib in advanced hepatocellular carcinoma (HCC): considerations for treatment
    Kyung Kim
    Reena Jha
    Petra A. Prins
    Hongkun Wang
    Monica Chacha
    Marion L. Hartley
    Aiwu Ruth He
    Cancer Chemotherapy and Pharmacology, 2017, 80 : 945 - 954
  • [23] Phase 1/2 study of durvalumab and tremelimumab as monotherapy and in combination in patients with unresectable hepatocellular carcinoma (HCC)
    Abou-Alfa, Ghassan K.
    Sangro, Bruno
    Morse, Michael
    Zhu, Andrew X.
    Kim, Richard D.
    Cheng, Ann-Lii
    Kudo, Masatoshi
    Kang, Yoon-Koo
    Chan, Stephen L.
    Antal, Joyce
    Boice, Jillian
    Xiao, Feng
    Morris, Shannon R.
    Bendell, Johanna
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [24] Candidates for Surveillance for Hepatocellular Carcinoma (HCC) Among Patients with Advanced Cirrhosis in the United States
    Flemming, Jennifer A.
    Kim, W. Ray
    Stock, Peter
    Terrault, Norah
    HEPATOLOGY, 2012, 56 : 1091A - 1091A
  • [25] Nivolumab (Nivo) in Patients (Pts) With Advanced Hepatocellular Carcinoma (HCC): the CheckMate 040 Study
    Melero, Ignacio
    Sangro, Bruno
    Yau, Thomas
    Hsu, Chiun
    Kudo, Masatoshi
    Crocenzi, Todd S.
    Kim, Tae-You
    Choo, Su-pin
    Trojan, Jorg
    Meyer, Timothy
    Welling, Theodore
    Yeo, Winnie
    Chopra, Akhil
    Anderson, Jeffrey
    Delacruz, Christine
    Lang, Lixin
    Neely, Jaclyn
    Tang, Hao
    El-Khoueiry, Anthony B.
    HEPATOLOGY, 2016, 64 (06) : 1124A - 1124A
  • [26] Early toxicity of sunitinib as a potential predictive biomarker in advanced hepatocellular carcinoma (HCC) patients
    Duda, G. D.
    Ancukiewicz, M.
    Clark, J. W.
    Miksad, R. A.
    Fuchs, C.
    Ryan, D. P.
    Jain, R. K.
    Zhu, A. X.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [27] Concomitant use of antiacids in patients with advanced hepatocellular carcinoma (HCC) receiving sorafenib therapy
    Razak, Razwan Abd
    Kunene, Victoria
    Ma, Yuk Ting
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [28] Phase I study of everolimus in combination with sorafenib in patients with advanced hepatocellular carcinoma (HCC).
    Finn, R. S.
    Poon, R. T. P.
    Yau, T.
    Klumpen, H.
    Chen, L.
    Kang, Y.
    Kim, T.
    Gomez-Martin, C.
    Rodriguez-Lope, C.
    Kunz, T.
    Paquet, T.
    Asubonteng, K.
    Winkler, R. E.
    Anak, O.
    Sellami, D. B.
    Bruix, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [29] Early experience of combination treatment of sorafenib and radiotherapy in patients with advanced hepatocellular carcinoma (HCC)
    Seong, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (04)
  • [30] Treatment of patients with advanced hepatocellular carcinoma(HCC) with transarterial 188Re-Lipiodol
    Chen, S. L.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2007, 34 : S188 - S189
12345